The development of minimally invasive continuous Metabolic Monitoring Technologies in the U.S. Army TMM Research Program.
The Technologies for Metabolic Monitoring and Julia Weaver Fund Research Program (TMM) promotes the development of minimally invasive, innovative technologies for the monitoring and assessment of metabolic changes that are important to the management of diabetes. This program also promotes the advancement of biological monitoring technologies for healthy individuals operating in extreme environments, such as soldiers and astronauts. These technologies have focused on measurements of analytes in interstitial fluids and functional outcomes related to glucose regulation. TMM investigators have advanced new sensing methods and are working to overcome technological barriers to long-term implants. This paper reviews the current goals, research areas, and future direction of the program.
Hover
Carl G
CG
Military Operational Medicine Research Program, U.S. Army Medical Research and Materiel Command, Frederick, Maryland, USA. Carl.Hover@us.army.mil
Stedeford
Todd
T
Vigneulle
Roy M
RM
D000465:Algorithms; D001786:Blood Glucose / Q000032:analysis*; D003920:Diabetes Mellitus / Q000097:blood; D004594:Electrophysiology / Q000379:methods; D005260:Female; D005949:Glucose Oxidase; D006801:Humans; D008297:Male; D008889:Military Personnel; D018670:Monitoring, Ambulatory / Q000379:methods*; D011379:Prognosis; D014481:United States
D001786:Blood Glucose; D005949:Glucose Oxidase